Insider Transactions in Q2 2023 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
105
-0.14%
|
$945
$9.5 P/Share
|
|
Jun 05
2023
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
6,486
-4.75%
|
$58,374
$9.5 P/Share
|
|
May 17
2023
|
Erick Lucera EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
77,900
+50.0%
|
-
|
|
May 11
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
668
-0.86%
|
$6,012
$9.87 P/Share
|
|
May 11
2023
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
949
-0.88%
|
$8,541
$9.87 P/Share
|
|
May 09
2023
|
Bruce Eaton EVP, CBO AND CTO |
SELL
Open market or private sale
|
Direct |
135
-0.17%
|
$1,215
$9.51 P/Share
|